SCHEMBL1050267

SCHEMBL1050267

CC(O)C(OCCO)OCCO

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15524338 0.85 MEN1 (0.50) ALDH1A1TSHRMAPK1MEN1KMT2A
SCHEMBL3644301 0.84 TDP1 (0.30) TDP1
SCHEMBL27754438 0.83 HSD17B10 (0.44) TDP1TSHR
SCHEMBL23817271 0.80
SCHEMBL7540597 0.78
SCHEMBL26641882 0.77 HSD17B10 (0.39) TDP1
SCHEMBL12285378 0.77
SCHEMBL765642 0.77
SCHEMBL17656329 0.77
SCHEMBL28030709 0.75 MEN1 (0.44) ALDH1A1TSHRMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451974-A2 OLIGONUCLEOTIDE-BASED COMPOUNDS AS INHIBITORS OF TOLL-LIKE RECEPTORS Idera Pharmaceuticals, Inc. (US) 2012-05-16 EP claimed
WO-2011005942-A2 OLIGONUCLEOTIDE-BASED COMPOUNDS AS INHIBITORS OF TOLL-LIKE RECEPTORS IDERA PHARMACEUTICALS, INC. (US) 2011-01-13 WO claimed
EP-2179061-A2 TOLL LIKE RECEPTOR MODULATORS Idera Pharmaceuticals, Inc. (US) 2010-04-28 EP claimed
JP-2009533348-A 2009-09-17 JP claimed
WO-2009023819-A2 TOLL LIKE RECEPTOR MODULATORS IDERA PHARMACEUTICALS, INC. (US) 2009-02-19 WO claimed
EP-2021008-A2 STABILIZED IMMUNE MODULATORY RNA (SIMRA) COMPOUNDS FOR TLR7 AND TLR8 Idera Pharmaceuticals, Inc. (US) 2009-02-11 EP claimed
WO-2007117686-A2 STABILIZED IMMUNE MODULATORY RNA (SIMRA) COMPOUNDS FOR TLR7 AND TLR8 IDERA PHARMACEUTICALS, INC. (US) 2007-10-18 WO claimed
US-20160022826-A1 CARBOHYDRATE-MODIFIED GLYCOPROTEINS AND USES THEREOF LUMOS PHARMA, INC. 2016-01-28 US disclosed